Conventional and novel tools for defining the risk of the individual patient with chronic myeloid leukemia and for monitoring treatment

Haematologica. 2004 Jan;89(1):6-9.
No abstract available

Publication types

  • Comment
  • Editorial
  • Review

MeSH terms

  • Disease-Free Survival
  • Humans
  • Leukemia, Myelogenous, Chronic, BCR-ABL Positive / epidemiology*
  • Leukemia, Myelogenous, Chronic, BCR-ABL Positive / genetics*
  • Neoplasm Recurrence, Local / epidemiology*
  • Neoplasm Recurrence, Local / genetics
  • Neoplasm Recurrence, Local / mortality*
  • Remission Induction / methods
  • Risk Factors